We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The vaccine candidate is stable at room temperature, which offers “an enormous logistical advantage in large vaccination campaigns,” the company said. Read More
Information gathered from testing patients’ antibody neutralizing capacity “could be used in the development of COVID-19 vaccines and the screening of convalescent plasma for prophylactic and therapeutic use,” the company said. Read More